| Monitoring and management of heparin-induced thrombocytopenia. | |
| | |
MedLine Citation:
|
PMID: 20081589 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Low molecular weight heparins have been used to reduce thromboembolic risk for at least 20 years, but their use is not without risk. This article considers the incidence, monitoring, treatment and lack of insight about heparin-induced thrombocytopenia - a potentially fatal complication of low molecular weight heparin use. |
| | |
Authors:
|
Ba Rogers; Nj Little; C Jones |
Related Documents
:
|
20174769 - Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis. 11836169 - Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: hepa... 16674999 - What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombo... 11487029 - Risk factors in venous thromboembolism. 19786939 - Polymorphisms in exons 6 and 7 of the abo locus and their association with venous throm... 10521389 - Prothrombin g20210a gene mutation and further prothrombotic risk factors in childhood t... 21957059 - Women have relatively larger brains than men: a comment on the misuse of general linear... 10668009 - Mmpi code types and the fantasy prone personality. 658559 - The rise in divorce rates, 1960-1974: age-specific omponents. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: British journal of hospital medicine (London, England : 2005) Volume: 70 ISSN: 1750-8460 ISO Abbreviation: Br J Hosp Med (Lond) Publication Date: 2009 Nov |
Date Detail:
|
Created Date: 2010-01-18 Completed Date: 2010-04-06 Revised Date: 2010-04-21 |
Medline Journal Info:
|
Nlm Unique ID: 101257109 Medline TA: Br J Hosp Med (Lond) Country: England |
Other Details:
|
Languages: eng Pagination: 630-3 Citation Subset: IM |
Affiliation:
|
Trauma and Orthopaedics, St George's Hospital, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
adverse effects*,
therapeutic use Enzyme-Linked Immunosorbent Assay Heparin, Low-Molecular-Weight / adverse effects*, therapeutic use Humans Practice Guidelines as Topic* Thrombocytopenia / chemically induced*, diagnosis Thromboembolism / prevention & control* |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Heparin, Low-Molecular-Weight |
| Comments/Corrections | |
Comment In:
|
Br J Hosp Med (Lond). 2009 Dec;70(12):723
[PMID:
20112439
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Specialty and curriculum development.
Next Document: Slowing the progression of chronic kidney disease.